FCX
65
6
LRCX
43
-2
PBI
60
17
LUV
39
-5
LLY
37
-2
DVN
43
7
EXPE
74
2
BBY
43
3
PNR
65
3
XYL
35
2
MAC
67
2
EMR
50
2
JWN
52
2
HRB
54
2
OKE
65
4
VZ
32
-2
VNO
52
-8
GIS
26
-14
DAL
77
-3
AMG
22
-16
FCX
65
6
LRCX
43
-2
PBI
60
17
LUV
39
-5
LLY
37
-2
DVN
43
7
EXPE
74
2
BBY
43
3
PNR
65
3
XYL
35
2
MAC
67
2
EMR
50
2
JWN
52
2
HRB
54
2
OKE
65
4
VZ
32
-2
VNO
52
-8
GIS
26
-14
DAL
77
-3
AMG
22
-16
Financhill
Back

Actinium Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Sell
35

ATNM
Actinium Pharmaceuticals

Last Price:
1.77
Seasonality Move:
-1.83%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.01
Seasonality Move:
26.28%
Sell
35
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy, Sell or Hold?

  • The current Actinium Pharmaceuticals [ATNM] share price is $1.76. The Score for ATNM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ATNM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATNM Stock Price Chart

What is Actinium Pharmaceuticals's stock price today?

  • The Actinium Pharmaceuticals share price today is $1.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

ATNM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 46.65 Sell
Chaikin Money Flow: 158788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.68 - 1.84) Sell
Bollinger Bands (100): (1.21 - 6.51) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 46.93 Sell
Chaikin Money Flow: -154562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.92 - 13.12) Sell
Bollinger Bands (100): (11.23 - 14.35) Sell

ATNM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.77 Sell
20-day SMA: 1.74 Buy
50-day SMA: 1.81 Sell
200-day SMA: 5.72 Sell
8-day EMA: 1.77 Sell
20-day EMA: 1.78 Sell
50-day EMA: 2.25 Sell
200-day EMA: 4.74 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.85 Buy
20-day SMA: 12.37 Sell
50-day SMA: 13.45 Sell
200-day SMA: 12.59 Sell
8-day EMA: 12 Buy
20-day EMA: 12.31 Sell
50-day EMA: 12.84 Sell
200-day EMA: 11.76 Buy

Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.66 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

Actinium Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):